Annual SG&A:
$72.98M-$3.19M(-4.18%)Summary
- As of today, CRSP annual SG&A is $72.98 million, with the most recent change of -$3.19 million (-4.18%) on December 31, 2024.
- During the last 3 years, CRSP annual SG&A has fallen by -$26.71 million (-26.80%).
- CRSP annual SG&A is now -28.78% below its all-time high of $102.46 million, reached on December 31, 2022.
Performance
CRSP SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$18.92M-$380.00K(-1.97%)Summary
- As of today, CRSP quarterly SG&A is $18.92 million, with the most recent change of -$380.00 thousand (-1.97%) on June 30, 2025.
- Over the past year, CRSP quarterly SG&A has dropped by -$565.00 thousand (-2.90%).
- CRSP quarterly SG&A is now -36.54% below its all-time high of $29.81 million, reached on June 30, 2021.
Performance
CRSP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$5.91B-$467.80M(-8.60%)Summary
- As of today, CRSP TTM SG&A is -$5.91 billion, with the most recent change of -$467.80 million (-8.60%) on June 30, 2025.
- Over the past year, CRSP TTM SG&A has dropped by -$5.98 billion (-8281.04%).
- CRSP TTM SG&A is now -17321.81% below its all-time high of -$33.91 million.
Performance
CRSP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
CRSP Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -4.2% | -2.9% | -8281.0% |
| 3Y3 Years | -26.8% | -28.0% | -5847.7% |
| 5Y5 Years | +14.9% | -11.4% | -7510.3% |
CRSP Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -28.8% | at low | -29.9% | +14.8% | -216.3% | at low |
| 5Y | 5-Year | -28.8% | +14.9% | -36.5% | +14.8% | -967.7% | at low |
| All-Time | All-Time | -28.8% | +1327.0% | -36.5% | +784.3% | >-9999.0% | at low |
CRSP Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $18.92M(-2.0%) | $73.75M(-0.8%) |
| Mar 2025 | - | $19.30M(+6.5%) | $74.32M(+1.8%) |
| Dec 2024 | $72.98M(-4.2%) | $18.12M(+4.0%) | $72.98M(+2.3%) |
| Sep 2024 | - | $17.42M(-10.6%) | $71.33M(-1.2%) |
| Jun 2024 | - | $19.48M(+8.5%) | $72.20M(+0.6%) |
| Mar 2024 | - | $17.95M(+8.9%) | $71.75M(-5.8%) |
| Dec 2023 | $76.16M(-25.7%) | $16.48M(-9.9%) | $76.16M(-5.8%) |
| Sep 2023 | - | $18.29M(-3.9%) | $80.85M(-9.7%) |
| Jun 2023 | - | $19.03M(-14.9%) | $89.56M(-7.5%) |
| Mar 2023 | - | $22.36M(+5.6%) | $96.80M(-5.5%) |
| Dec 2022 | $102.46M(+2.8%) | $21.17M(-21.6%) | $102.46M(-2.8%) |
| Sep 2022 | - | $27.00M(+2.8%) | $105.42M(+2.6%) |
| Jun 2022 | - | $26.27M(-6.2%) | $102.77M(-3.3%) |
| Mar 2022 | - | $28.02M(+16.1%) | $106.31M(+3.4%) |
| Dec 2021 | $99.69M(+13.0%) | $24.13M(-0.9%) | $102.80M(-1.6%) |
| Sep 2021 | - | $24.35M(-18.3%) | $104.44M(+2.8%) |
| Jun 2021 | - | $29.81M(+21.6%) | $101.63M(+9.1%) |
| Mar 2021 | - | $24.52M(-4.8%) | $93.17M(+5.6%) |
| Dec 2020 | $88.21M | $25.77M(+19.6%) | $88.21M(+10.7%) |
| Sep 2020 | - | $21.54M(+0.9%) | $79.71M(+8.2%) |
| Jun 2020 | - | $21.35M(+9.2%) | $73.69M(+8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $19.55M(+13.2%) | $68.11M(+7.3%) |
| Dec 2019 | $63.49M(+31.5%) | $17.27M(+11.3%) | $63.49M(+1.2%) |
| Sep 2019 | - | $15.52M(-1.6%) | $62.76M(+9.3%) |
| Jun 2019 | - | $15.77M(+5.6%) | $57.41M(+5.6%) |
| Mar 2019 | - | $14.93M(-9.8%) | $54.39M(+12.6%) |
| Dec 2018 | $48.29M(+34.7%) | $16.54M(+62.6%) | $48.29M(+12.1%) |
| Sep 2018 | - | $10.18M(-20.1%) | $43.08M(+5.0%) |
| Jun 2018 | - | $12.74M(+44.2%) | $41.01M(+13.8%) |
| Mar 2018 | - | $8.84M(-22.0%) | $36.04M(+0.5%) |
| Dec 2017 | $35.84M(+15.4%) | $11.32M(+39.6%) | $35.84M(-2.1%) |
| Sep 2017 | - | $8.11M(+4.4%) | $36.60M(+12.3%) |
| Jun 2017 | - | $7.77M(-10.1%) | $32.60M(-2.9%) |
| Mar 2017 | - | $8.64M(-28.5%) | $33.58M(+8.1%) |
| Dec 2016 | $31.06M(+131.7%) | $12.08M(+194.2%) | $31.06M(+63.7%) |
| Sep 2016 | - | $4.11M(-53.1%) | $18.97M(+27.6%) |
| Jun 2016 | - | $8.75M(+43.1%) | $14.87M(+80.1%) |
| Mar 2016 | - | $6.12M(+185.9%) | $8.26M(+75.2%) |
| Dec 2015 | $13.40M(+162.1%) | - | - |
| Jun 2015 | - | $2.14M(-16.8%) | $4.71M(+83.2%) |
| Mar 2015 | - | $2.57M | $2.57M |
| Dec 2014 | $5.11M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual SG&A?
- What is the all-time high annual SG&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual SG&A year-on-year change?
- What is CRISPR Therapeutics AG quarterly SG&A?
- What is the all-time high quarterly SG&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly SG&A year-on-year change?
- What is CRISPR Therapeutics AG TTM SG&A?
- What is the all-time high TTM SG&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM SG&A year-on-year change?
What is CRISPR Therapeutics AG annual SG&A?
The current annual SG&A of CRSP is $72.98M
What is the all-time high annual SG&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual SG&A is $102.46M
What is CRISPR Therapeutics AG annual SG&A year-on-year change?
Over the past year, CRSP annual SG&A has changed by -$3.19M (-4.18%)
What is CRISPR Therapeutics AG quarterly SG&A?
The current quarterly SG&A of CRSP is $18.92M
What is the all-time high quarterly SG&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly SG&A is $29.81M
What is CRISPR Therapeutics AG quarterly SG&A year-on-year change?
Over the past year, CRSP quarterly SG&A has changed by -$565.00K (-2.90%)
What is CRISPR Therapeutics AG TTM SG&A?
The current TTM SG&A of CRSP is -$5.91B
What is the all-time high TTM SG&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM SG&A is -$33.91M
What is CRISPR Therapeutics AG TTM SG&A year-on-year change?
Over the past year, CRSP TTM SG&A has changed by -$5.98B (-8281.04%)